Labor and Delivery Complication clinical trials at University of California Health
1 in progress, 0 open to eligible people
Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial
Sorry, not currently recruiting here
This is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either adjunctive azithromycin prophylaxis or to placebo. Both groups also will receive standard of care preoperative antibiotics (excluding azithromycin). The primary endpoint is a maternal infection composite defined as any one of the following up to 6 weeks postpartum: endometritis, wound infection, abscess, septic thrombosis, sepsis, pneumonia, pyelonephritis and breast infection.
at UCSF
Our lead scientists for Labor and Delivery Complication research studies include Mary Norton, MD.
Last updated: